Sarepta Therapeutics Inc.
SRPT | NASDAQ
$20.83
+$0.69 (+3.43%)
Sep 22, 2026, 1:24 PM ET · Market open
Market Data
Market Cap $2.13B
Enterprise Value $2.38B
Beta 0.21
Average Volume 3.25M
Shares Outstanding (Diluted) 105.43M
Shares Change YoY -1.12%
Institutional Ownership 98.04%
Exchange NASDAQ
ISIN US8036071004
Price Performance
Price Change 1M 8.4%
Price Change 3M 16.6%
Price Change 6M -15.4%
Price Change YTD -5.6%
Price Change 1Y 7.9%
Price Change 3Y -83.2%
Price Change 5Y -77.8%
1M CAGR (ann.) 20.0%
1Y CAGR (ann.) 8.8%
5Y CAGR (ann.) -24.4%
All-Time CAGR -1.2%
Valuation
PE Ratio -6.94
Forward PE 25.46
PEG Ratio 0.02
Forward PEG 0.18
PS Ratio 1.08
Forward PS 1.50
PB Ratio 1.39
P/FCF Ratio -16.16
P/Adj. FCF Ratio -8.18
P/OCF Ratio -23.13
EV/Sales 1.21
EV/EBIT -40.17
EV/EBITDA -163.31
EV/FCF -18.12
Earnings Yield -14.4%
FCF Yield -6.2%
Adj. FCF Yield -12.2%
Financial Health
Net Debt $59.13M
Total Debt $1.05B
Cash & Short-Term Investments $788.49M
Total Assets $3.19B
Current Ratio 4.42
Quick Ratio 2.62
Debt / Equity Ratio 0.68
Debt / EBITDA -71.71
Debt / FCF -7.96
OCF / Debt -0.09
Interest Coverage -2.45
Altman Z-Score -0.02
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 58.6%
Operating Profit Margin -7.3%
EBITDA Margin -0.7%
Net Profit Margin -6.9%
FCF Margin -6.7%
Adj. FCF Margin -13.2%
SBC / Revenue 6.5%
SBC Impact (per share) -97.5%
Returns
Return on Assets -4.3%
Return on Equity -10.0%
Return on Invested Capital -5.3%
Return on Capital Employed -5.3%
Return on Tangible Assets -4.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 25.3%
Revenue CAGR 5Y 26.9%
Revenue CAGR 10Y 108.8%
EPS CAGR 3Y -147.3%
EPS CAGR 5Y 39.4%
EPS CAGR 10Y 6.0%
FCF CAGR 3Y 53.4%
FCF CAGR 5Y 12.8%
FCF CAGR 10Y -2.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 55
EPS Growth Next 3Y 53.7%
Revenue Growth Next 3Y -12.8%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $0.17
EPS Growth Est (next Q) -109.6%
Revenue Est (next Q) $354.66M
Revenue Growth Est (next Q) -11.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $23.33
Price Target Upside 16.0%
Cash Flow
Operating Cash Flow $-91.68M
Free Cash Flow $-131.47M
Adj. Free Cash Flow $-259.68M
FCF Per Share -$1.25
OCF Per Share -$0.87
OCF/S Ratio -4.6%
Income Statement
Revenue $1.97B
Gross Profit $1.16B
Operating Income $-143.25M
EBITDA $-14.58M
Net Income $-136.73M
EPS (Diluted) -$2.90
Revenue / Employee $2.36M
Profit / Employee $-163.74K
Employees 835
Add to Watchlist
Select watchlists to add or remove SRPT